How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

52,439 results for

Topical Paste

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. ‘White whale’ is a ghost of sperm whales’ past

‘White whale’ is a ghost of sperm whales’ past 'White whale' is a ghost of sperm whales' past | PLOS Blogs Network PLOS Blogs Staff Blogs Blogs by Topic Biology & Life Sciences Earth & Environmental Sciences Multi-disciplinary Sciences Medicine & Health Research Analysis & Scientific Policy Diverse perspectives on science and medicine Staff Blogs Blogs by Topic Biology & Life Sciences Earth & Environmental Sciences Multi-disciplinary Sciences Medicine & Health Research Analysis & Scientific

2015 PLOS Blogs Network

182. Jim Carrey’s antivaccine rants are nothing new (a blast from the past, featuring Fire Marshal Bill)

Jim Carrey’s antivaccine rants are nothing new (a blast from the past, featuring Fire Marshal Bill) Jim Carrey's antivaccine rants are nothing new (a blast from the past, featuring Fire Marshal Bill) | ScienceBlogs Advertisment Search Search Toggle navigation Main navigation Jim Carrey's antivaccine rants are nothing new (a blast from the past, featuring Fire Marshal Bill) By on July 2, 2015. In the wake of the passage of SB 277 into law in California, the antivaccine contingent went . SB 277 (...) , which is part of why McCarthy was originally attracted to him in the first place. Whatever the case, given that Jim Carrey has reminded us just how antivaccine he is, I thought today was a perfect time for a little blast from the past to remind people just how antivaccine Jim Carrey has been at least since 2009, with a little blast from the past, when I imagined Fire Marshal Bill going antivaccine. It came then out of a sincere motivation to give the people what they wanted, and my reposting

2015 Respectful Insolence

183. Ocular-hypertensive Response to Topical Steroids in Children After Bilateral Strabismus Surgery

Ocular-hypertensive Response to Topical Steroids in Children After Bilateral Strabismus Surgery Ocular-hypertensive Response to Topical Steroids in Children After Bilateral Strabismus Surgery - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. Ocular-hypertensive Response to Topical Steroids in Children After Bilateral Strabismus Surgery The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02816905 Recruitment Status : Completed First Posted : June 29, 2016 Last Update Posted : June 29, 2016 Sponsor: Cairo

2016 Clinical Trials

184. Safety and Efficacy of Topical AR/101 Compared With Placebo, in Accelerating Granulation Tissue Formation of Hard-to-heal Wounds

Safety and Efficacy of Topical AR/101 Compared With Placebo, in Accelerating Granulation Tissue Formation of Hard-to-heal Wounds Safety and Efficacy of Topical AR/101 Compared With Placebo, in Accelerating Granulation Tissue Formation of Hard-to-heal Wounds - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have (...) reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Safety and Efficacy of Topical AR/101 Compared With Placebo, in Accelerating Granulation Tissue Formation of Hard-to-heal Wounds The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02839226 Recruitment

2016 Clinical Trials

185. Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers

Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Topical Sodium Nitrite in Sickle (...) Center Collaborator: Food and Drug Administration (FDA) Information provided by (Responsible Party): Caterina Minniti, Montefiore Medical Center Study Details Study Description Go to Brief Summary: The investigators propose a Phase II study, prospective and placebo controlled, of a topical cream containing sodium nitrite compared to the current standard of care. Sodium nitrite is a local donor of nitric oxide, which is known to improve blood flow and decrease bacterial load in the ulcer bed

2016 Clinical Trials

186. Effect of Topical Phenylephrine 2.5% on EVP in Normal Human Eyes

episcleral vein for measurement. Ocular trauma within the past 6 months. Ocular infection or ocular inflammation in the past 3 months. Ocular medication of any kind within 30 days of study visit. Known hypersensitivity to Phenylephrine or topical anesthetic medication. Severe hypertension: Systolic blood pressure greater than 180 mmHg and/or diastolic blood pressure greater than 105 mmHg. A known history of ischemic heart disease (angina or myocardial infarction), cerebrovascular accidents, cardiac (...) Effect of Topical Phenylephrine 2.5% on EVP in Normal Human Eyes Effect of Topical Phenylephrine 2.5% on EVP in Normal Human Eyes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effect of Topical

2016 Clinical Trials

187. Delivra Topical Creatine for Improving Muscular Power

Delivra Topical Creatine for Improving Muscular Power Delivra Topical Creatine for Improving Muscular Power - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Delivra Topical Creatine for Improving Muscular (...) ) is the immediate source of energy in muscle - during exercise ATP is broken down to Adenosine Diphosphate (ADP) and inorganic phosphate. Duration of high-intensity exercise is limited to a few seconds based on limited ATP stores in muscle. PCr acts to re-phosphorylate ADP to form ATP so that muscle contraction can continue at high intensities. After creatine monohydrate is ingested, high-intensity exercise capacity is increased because of the increased PCr stores in muscle. Delivra Inc. has developed a topical

2016 Clinical Trials

188. Topical Infliximab for Sterile Corneal Melt

Topical Infliximab for Sterile Corneal Melt Topical Infliximab for Sterile Corneal Melt - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Topical Infliximab for Sterile Corneal Melt The safety and scientific (...) . In this situation, infliximab was used intravenous (using veins) in order to treat the whole body. This study's hypothesis is that infliximab can safely be used as eye drops for the treatment of sterile corneal melt. Condition or disease Intervention/treatment Phase Sterile Corneal Melt Drug: Topical Infliximab Phase 1 Detailed Description: This is an unmasked, prospective, single-center trial of twelve patients with sterile corneal melt and an underlying auto-immune or inflammatory disease, such as rosacea

2016 Clinical Trials

189. The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer

The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02769494 Recruitment Status : Unknown Verified January 2016 by Yongquan Shi, Xijing Hospital

2016 Clinical Trials

190. Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa

Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Topical BPM31510 3.0 (...) Collaborator: Berg, LLC Information provided by (Responsible Party): Shasa Hu, University of Miami Study Details Study Description Go to Brief Summary: This is a single-center study to investigate the effects of a topical cream on patients 12 years of age and older that have been diagnosed with epidermolysis bullosa. Condition or disease Intervention/treatment Phase Epidermolysis Bullosa Drug: topical BPM31510 3.0% Cream Phase 1 Detailed Description: The trial will be conducted in patients with any form

2016 Clinical Trials

191. Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study (...) Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov

2016 Clinical Trials

192. Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis

Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02999776 Recruitment Status : Unknown Verified December 2016

2016 Clinical Trials

193. Delivra Topical Creatine Combined With Oral Creatine for Improving Muscular Power

Delivra Topical Creatine Combined With Oral Creatine for Improving Muscular Power Delivra Topical Creatine Combined With Oral Creatine for Improving Muscular Power - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Delivra Topical Creatine Combined With Oral Creatine for Improving Muscular Power The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03006861 Recruitment Status : Completed First Posted : December 30, 2016 Last Update Posted : June 28, 2018 Sponsor: University of Saskatchewan Collaborators

2016 Clinical Trials

194. Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia

studied, anabolic steroids, or over-the-counter "hair restorers"; Use of the following drugs with antiandrogenic properties within 6 months of study entry: flutamide, cyproterone acetate, estrogen, progesterone, cimetidine, spironolactone or ketoconazole; Patients who had been treated with any of the following drugs within the past year: minoxidil (topical or oral), zidovudine, cyclosporine, diazoxide, phenytoin, systemic interferon, psoralens, streptomycin, penicillamine, benoxaprofen, tamoxifen (...) Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2016 Clinical Trials

195. Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products

with error rate < 1 %/year no sex vasectomy of the partner Diseases of the facial skin other than acne No concomitant topical medications (including make-up) or keratolytics as sulphur, salicylic acid, benzoyl peroxide, resorcin and abradents and acid-containing peels one week before the study starts Patients who had facial procedures (chemical peel, laser therapy, photodynamic therapy, microdermabrasion, or UV light therapy) within the past 4 weeks No concomitant participation in other studies within (...) the past 30 days Hypersensitivity against any ingredients of Acnatac® -gel or Epiduo®gel Systemic medication with antibiotics or antibiotics within the last 4 weeks before study start Systemic medication with retinoids within the last 6 months before study start Topical treatment of acne vulgaris within the last two weeks before study Acne fulminans, Severe systemic disease respectively taking immunosuppressive drugs Severe liver disease Severe renal disease History or presence of regional enteritis

2016 Clinical Trials

196. BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes

BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. BPX-01 (...) Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02709096 Recruitment Status : Completed First Posted : March 15, 2016 Results First Posted : September 14, 2017 Last Update Posted : September 14, 2017 Sponsor: BioPharmX, Inc. Information

2016 Clinical Trials

197. The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) ®

The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) ® The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) ® - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) ® The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02735837 Recruitment Status : Completed First Posted : April 13, 2016 Last Update Posted : October 4, 2016 Sponsor

2016 Clinical Trials

198. Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis

, inclusive Diagnosis of moderate or greater Atopic Dermatitis as determined by the Physician's Global Assessment (PGA of 3 or 4) Exclusion Criteria: Is currently participating or has participated in another interventional clinical study at this or any other facility in the past 2 weeks Currently or has been diagnosed or treated for cancer in the past 5 years. Requires any topical or systemic medications that could affect the course of their atopic dermatitis during the study period (except inhaled (...) steroids and/or stable antihistamines for asthma or allergies). Has a known hypersensitivity to any corticosteroid creams. Has a known sensitivity to Epinephrine, Xylocaine or topical antibiotics. Has a wound healing or blood-clotting abnormality. Has any active infections or has used antibiotics in the past 7 days. Has any physical attributes or skin conditions that might interfere with the clear visual or instrumental assessments.(i.e. cuts, sunburn, birth marks, tattoos, extensive scarring

2016 Clinical Trials

199. Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty

Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02664909 Recruitment Status : Recruiting

2016 Clinical Trials

200. A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI

A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02723539 Recruitment Status : Active, not recruiting First Posted : March 30, 2016 Last Update Posted : August 15, 2018

2016 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>